<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615155</url>
  </required_header>
  <id_info>
    <org_study_id>Sajjad Ahmed Shakir</org_study_id>
    <nct_id>NCT05615155</nct_id>
  </id_info>
  <brief_title>Efficacy of C-PRF vs i-PRF in Thin Gingival Biotype Subjects</brief_title>
  <official_title>Efficacy of C-PRF Versus i-PRF on Gingival Thickness &amp; Keratinized Tissue Width in Subjects With Thin Gingival Biotype: ( Split Mouth Controlled Clinical Trials)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sajjad Ahmed Shakir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Baghdad</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf&#xD;
      versus c-prf injections on gingival thickness and keratinized tissue width in subjects with&#xD;
      thin gingival biotype.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized split mouth clinical trials study focused on comparing the efficacy of i-prf&#xD;
      versus c-prf injections on gingival thickness and keratinized tissue width in subjects with&#xD;
      thin gingival biotype.&#xD;
&#xD;
      Gingival biotype is an important clinical parameter that plays an important role in&#xD;
      determining the gingival health in the future and the possibility of developing gingival&#xD;
      recession or other gingival unhealthy condition that is related to thin gingival biotype.&#xD;
&#xD;
      Gingival biotype is consist of gingival thickness and keratinized tissue width, and its&#xD;
      either thin or thick, and the later is more favourable to withstand the developing of&#xD;
      gingival diseases and unhealthy condition, with this study we compare the effect of i-PRF&#xD;
      injection which is approved in many previous clinical trials that it affects the gingival&#xD;
      biotype and increases gingival thickness and the keratinized tissue width, and compare it to&#xD;
      newly developed PRF generation (C-PRF) which is Concentrated Platelet Rich Fibrin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2022</start_date>
  <completion_date type="Actual">November 1, 2022</completion_date>
  <primary_completion_date type="Actual">November 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>measure the mean differences gain of GT&amp;KTW</measure>
    <time_frame>baseline and 3 months</time_frame>
    <description>the increase in gingival thickness and keratinized tissue width after the injection of prf concentrates.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measure the mean difference gain of GT&amp;KTW</measure>
    <time_frame>baseline and 1 month</time_frame>
    <description>the increase in gingival thickness and keratinized tissue width after the injection of prf concentrates.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Thin Gingival Biotype</condition>
  <arm_group>
    <arm_group_label>i-PRF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The sides of the mouth that will be injected with injectable-Platelets Rich Fibrin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C-PRF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The sides of the mouth that will be injected with Concentrated-Platelets Rich Fibrin</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Platelets Rich Fibrin (i-PRF / C-PRF)</intervention_name>
    <description>one site of the mouth will be injected with i-PRF and the other site will be injected with C-PRF</description>
    <arm_group_label>C-PRF</arm_group_label>
    <arm_group_label>i-PRF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age ≥18 years and no systemic disease or pregnancy.&#xD;
&#xD;
          2. Non-smoker.&#xD;
&#xD;
          3. Subjects with clinically healthy intact periodontium; bleeding on probing (BOP)&lt;10%,&#xD;
             probing pocket depth (PPD)≤3mm, intact periodontium (no probing attachment loss).&#xD;
             (Chapple et al., 2018).&#xD;
&#xD;
          4. Four non-adjacent sites of anterior region with thin gingival biotype (GT ≤ 1mm).&#xD;
             (Patrick H. et al., 2018).&#xD;
&#xD;
          5. No malocclusion, crowding, filling, missing or supernumerary mandibular anterior&#xD;
             teeth.&#xD;
&#xD;
          6. No blood-borne conditions.&#xD;
&#xD;
          7. Any symptoms of recent acute illness e.g., COVID-19.&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Active orthodontic treatment.&#xD;
&#xD;
          2. Previous periodontal surgery.&#xD;
&#xD;
          3. Use of blood thinners.&#xD;
&#xD;
          4. Use of any drugs that might lead to gingival enlargement.&#xD;
&#xD;
          5. Attrition.&#xD;
&#xD;
          6. Gingival Recession.&#xD;
&#xD;
          7. Thick gingival biotype.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sajjad ah Shakir, BDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Baghdad</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Baghdad</name>
      <address>
        <city>Baghdad</city>
        <state>Alresafa</state>
        <zip>10011</zip>
        <country>Iraq</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 5, 2022</study_first_submitted>
  <study_first_submitted_qc>November 11, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 11, 2022</last_update_submitted>
  <last_update_submitted_qc>November 11, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Baghdad</investigator_affiliation>
    <investigator_full_name>Sajjad Ahmed Shakir</investigator_full_name>
    <investigator_title>bachelor of dental surgery</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>the study will be published and shared for other researchers in medical journals.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>it will be available in 2023/2024 and for no limits</ipd_time_frame>
    <ipd_access_criteria>data will be sent in e-mail for anyone wishes to access.&#xD;
sajjad.shakir1959@gmail.com</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 1, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/55/NCT05615155/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

